FDA Makes Good on Its Promise to Regulate Laboratory-Developed Tests | Sheppard Mullin Richter & Hampton LLP

Yesterday, the Food & Drug Administration (“FDA” or “the Agency”) issued a highly anticipated – and highly controversial – final rule, which rolls out a four-year, five-stage plan that...

Related Keywords

United States ,New York ,American , ,Friends Of Cancer Research ,Department Of Defense Do ,Supreme Court ,Public Health Service ,Sheppard Mullin Richter Hampton ,Veterans Health Administration ,Food Drug Administration ,Laboratory Developed ,York State Clinical Laboratory Evaluation Program ,College Of American Pathologists ,American Clinical Laboratory Association ,Academic Coalition For Effective Ldts ,Us Food Drug Administration Jan ,Sheppard Mullin Richter ,Drug Administration ,Laboratory Developed Tests ,Verifying Leading Edge ,Federal Food ,Cosmetic Act ,Public Health Service Act ,Out Enforcement Discretion ,Medical Device Reporting ,Quality System ,New York State ,Clinical Laboratory Evaluation Program ,Chevron Doctrine ,Draft Guidance ,Enforcement Policy ,Certain In Vitro Diagnostic Devices ,Immediate Public Health Response ,Enforcement Policies ,Tests During ,Frequently Asked Questions ,Press Release ,Summary Testimony ,Susan Van Meter ,Health Subcommittee ,House Energy ,Commerce Committee ,United States House ,Discussion Paper ,American Pathologists ,Cancer Research ,Academic Coalition ,Current Good Manufacturing Practices ,Pre Market Application ,